// App-Quantinova.ai

310 : Occurrence of dopaminergic adverse-events in COMT-naïve patients starting adjunctive therapy with opicapone: The BIPARK-I double-blind experience

Researchers

Presenter

  • K. Chaudhuri

Principal Investigators

  • A. Sauerbier

  • J. Ferreira

  • F. Stocchi

  • E. Arbe

  • J-F. Rocha

  • P. Soares-da-Silva

Medical Centers

  • N/A

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Orthostatic hypotension

Biomarkers

  • N/A

Drug/Treatment

  • Levodopa

Outcome

  • N/A

Study Design

  • Placebo Control

  • Double Blind/Blinded

  • Controlled

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved